A Granulomatous Chronic Disease Alexander J. Stockdale, MBChB, Claire L. Mackintosh, BSc(hon), MBChB, PhD, Katherine E. Roberston, BSc Hons, MBChB, PhD, Kristjan O. Helgason, Cand Med et Chir The American Journal of Medicine Volume 127, Issue 5, Pages e5-e6 (May 2014) DOI: 10.1016/j.amjmed.2013.12.012 Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 1 Computed tomography of abdomen demonstrating the liver abscess in the right lobe. The American Journal of Medicine 2014 127, e5-e6DOI: (10.1016/j.amjmed.2013.12.012) Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 2 Dihydrorhodamine test: Flow cytometry detects the oxidation of dihydrorhodamine to rhodamine 123 following neutrophil activation with phorbol myristate acetate (Normal control: Panels A and B). In a patient with X-linked chronic granulomatous disease, there is no detectable oxidative burst (panels C and D). The American Journal of Medicine 2014 127, e5-e6DOI: (10.1016/j.amjmed.2013.12.012) Copyright © 2014 Elsevier Inc. Terms and Conditions